Sun Pharma Q2 FY27 Earnings Call Recording Available

• The document is an intimation regarding the availability of the audio recording for Sun Pharmaceutical Industries Limited's Q2 FY27 earnings call.

• The earnings call was held on 30 October 2026, as indicated by the date of the disclosure and the reference to the call being held "today."

• The stated purpose of the event was to discuss the company's Q2 FY27 earnings, following up on a previous intimation dated 15th October 2026.

• The meeting occurred after the earnings announcement, as it is referred to as an "earnings call" and the recording is being made available post-event.

• Management participants are not specified in this particular disclosure.

• The audio recording of the call has been made available on the company's website at the specific URL: sunpharma.com/wp-content/uploads/2026/10/FY27-Q2-Earnings-Call-Recording-10047964.mp3

• The disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, but does not explicitly state whether unpublished price sensitive information (UPSI) was or was not shared during the call.

• No financial highlights, guidance references, or presentation summaries are included in this specific announcement.

Additional Notes Section:

• This disclosure serves as a follow-up to the company's earlier intimation dated 15th October 2026 regarding the earnings call.

• No financial data or figures are disclosed within this announcement; it solely provides access to the recording of the call where such information was likely discussed.

• The document is digitally signed by Anoop Deshpande, Company Secretary and Compliance Officer (ICSI Membership No.: A23983).